1/8
10:05 am
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) was given a new $5.00 price target on by analysts at Morgan Stanley.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) was given a new $5.00 price target on by analysts at Morgan Stanley.
1/5
07:00 am
rckt
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/26
10:24 am
rckt
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program [Seeking Alpha]
Low
Report
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program [Seeking Alpha]
12/20
07:27 am
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) was upgraded by analysts at TD Cowen to a "hold" rating.
Medium
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) was upgraded by analysts at TD Cowen to a "hold" rating.
12/17
07:22 am
rckt
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders [Yahoo! Finance]
12/15
11:16 pm
rckt
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position [Yahoo! Finance]
Low
Report
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position [Yahoo! Finance]
11/25
07:46 am
rckt
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/25
07:00 am
rckt
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Low
Report
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
11/18
01:13 pm
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target lowered by analysts at Bank of America Corporation from $10.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target lowered by analysts at Bank of America Corporation from $10.00 to $8.00. They now have a "buy" rating on the stock.
11/18
10:20 am
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
11/7
11:30 pm
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
11/6
04:28 pm
rckt
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]
11/6
04:00 pm
rckt
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Low
Report
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
10/26
06:47 am
rckt
Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? [Yahoo! Finance]
Low
Report
Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? [Yahoo! Finance]